Independent · Reader-Supported · Editorially Reviewed
§ Brand Review · GLP-1 Weight Loss

Embody Review

Flexible, medically guided compounded GLP-1 weight loss with transparent monthly pricing.

Last reviewed July 2026
4 studies cited
Fact-checked 18 July 2026Last updated 15 June 2026From $149 – $349/moEditor Score 4.4 / 5Trustpilot 3.8 · Average

Reader-supported, we may earn a commission through links on this site. Rankings are editorially independent. Disclosure · Methodology

Quick Verdict

Flexible, medically guided compounded GLP-1 weight loss with transparent monthly pricing.

Who it's for: Embody is the easy first-time pick for compounded GLP-1: clear pricing, single category focus, and no upsells into adjacent services. If you've tried two or three programs and want something that just does the GLP-1 piece well without complexity, Embody is a strong candidate. Less suited to anyone who wants brand-name Ozempic or Wegovy, or who needs TRT, ED, or hair loss support alongside weight loss.

Bottom line: Honest, simple, and focused. No brand-name GLP-1 access is the main trade-off, but for cost-conscious first-time users who just want a guided compounded GLP-1 program without upsells or complexity, that trade-off is rational. Transparent monthly pricing with no hidden fees is a genuine differentiator in a category where pricing opacity is common.

Pros
  • No hidden fees and no dose surcharges
  • Pure GLP-1 focus — no upsells into other categories
  • Reasonable entry price for a guided program
  • Transparent pricing disclosed before intake completion
Cons
  • Compounded only, no brand-name GLP-1 access
  • Single-category. won't help with adjacent goals

Pros & Cons In Detail

No hidden fees and no dose surcharges
In practice this is one of the differentiators that pushes Embody's editor score above the category median.
Pure GLP-1 focus — no upsells into other categories
In practice this is one of the differentiators that pushes Embody's editor score above the category median.
Reasonable entry price for a guided program
In practice this is one of the differentiators that pushes Embody's editor score above the category median.
Transparent pricing disclosed before intake completion
Clear, line-itemed pricing is increasingly rare in telehealth, and Embody discloses what you'll pay before you start a consult, not after card capture.
Compounded only, no brand-name GLP-1 access
It's a real trade-off worth knowing about before you commit, even if it isn't a deal-breaker on its own.
Single-category. won't help with adjacent goals
It's a real trade-off worth knowing about before you commit, even if it isn't a deal-breaker on its own.

Embody Pricing

Telehealth ads often advertise a low headline price that's the clinic's program fee, not the medication. Here's how the two line items break down at Embody.

Program / Membership FeeIncluded in monthly plan
Medication Cost (From)From $149 – $349/mo
What This Means For You

Transparent monthly pricing that bundles compounded GLP-1 medication, provider oversight, and shipping into a single fee. No separate membership charge, no dose surcharges, and no long-term contracts. Pricing is disclosed upfront before you complete intake.

Who Embody Is For

Embody is the easy first-time pick for compounded GLP-1: clear pricing, single category focus, and no upsells into adjacent services. If you've tried two or three programs and want something that just does the GLP-1 piece well without complexity, Embody is a strong candidate. Less suited to anyone who wants brand-name Ozempic or Wegovy, or who needs TRT, ED, or hair loss support alongside weight loss.

How Embody Markets Itself

First-time GLP-1 users who want a simple, no-frills compounded plan.

Signature Programs

  • ›Compounded semaglutide
  • ›Compounded tirzepatide
  • ›Provider-led titration

Medication Formulary

Full Formulary
compounded semaglutidecompounded tirzepatide

The Bottom Line

Honest, simple, and focused. No brand-name GLP-1 access is the main trade-off, but for cost-conscious first-time users who just want a guided compounded GLP-1 program without upsells or complexity, that trade-off is rational. Transparent monthly pricing with no hidden fees is a genuine differentiator in a category where pricing opacity is common.

With an editor score of 4.4 / 5 across cost, experience, and trust, Embody is one of the strong mid-tier options in the glp-1 weight loss category we cover.

See how Embody compares in our full glp-1 weight loss rankings, or read the Best Telehealth GLP-1 Providers guide. Our methodology explains how we score each provider.

§ FAQ

Frequently Asked Questions

References
  1. Wilding et al., NEJM 2021 (STEP 1) · Semaglutide 2.4 mg produced 14.9% mean weight loss vs 2.4% placebo at 68 weeks in the STEP 1 trial.
  2. FDA Federal Register 2024 (Semaglutide shortage end) · FDA removed semaglutide from the drug shortage list in October 2024, ending the legal basis for compounding.
  3. Jastreboff et al., NEJM 2022 (SURMOUNT-1) · Tirzepatide 15 mg produced 20.9% mean weight loss vs 3.1% placebo at 72 weeks in SURMOUNT-1.
  4. FDA Federal Register 2024 (Tirzepatide shortage end) · FDA removed tirzepatide from the drug shortage list in October 2024.

RxNotebook is an editorial publication. Citations point to peer-reviewed journals, FDA labeling, and clinical society guidelines. We are not affiliated with the studies cited above. This page is for general information and is not medical advice.

Alternatives To Embody

§ Continue Reading